Allan S Wagman

This inventor holds 28 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Lipid Synthesis Modulators. Top assignees: Novartis Vaccines & Diagnostics, Gmbh, Chiron Corporation, Novartis Ag. Active years: 2002-2026.

USPTO Granted Patents = 28 (Patent Applications = 6)

% Patents Active = 42.9

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 10 (Patent Applications = 5)

Average Co-Inventor Count = 8.0

ph-index = 9

Forward Citations = 340(Granted Patents)

Location History:

Oakland, CA (US) (2002 - 2008)
Emeryville, CA (US) (2010 - 2012)
Belmont, CA (US) (2006 - 2021)
San Maeo, CA (US) (2023)

Company Filing History:

9 out of 245

Novartis Vaccines & Diagnostics, Gmbh

3-V Biosciences, Inc.

patents

5. 4 out of 2,169

University of Washington

patents

6. 2 out of 3

Sagimet Biosciences Inc.

Saginiet Biosciences Inc.

patent

9. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Lipid Synthesis

CSF-1R Inhibitors

PI-3 Kinase Inhibitors

Antibacterial Agents

Glycogen Synthase Kinase 3

Quinazolines

Pyrimidine Derivatives

Thiosemicarbazones

Benzimidazole Quinolinones

Carbacephem Antibiotics

Heterocyclic Modulators

Pyrrole Inhibitors

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12551490 - Heterocyclic modulators of lipid synthesis (2026-02-17),

2. 11622968 - Heterocyclic modulators of lipid synthesis (2023-04-11),

3. 11034690 - Heterocyclic modulators of lipid synthesis (2021-06-15),

4. 10118913 - Heterocyclic modulators of lipid synthesis (2018-11-06),

5. 10053450 - Heterocyclic modulators of lipid synthesis (2018-08-21),

6. 9994550 - Heterocyclic modulators of lipid synthesis for use against cancer and viral infections (2018-06-12),

7. 9428502 - Heterocyclic modulators of lipid synthesis (2016-08-30),

8. 8710048 - 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling (2014-04-29),

9. 8563549 - Pyrimidine derivatives used as PI-3 kinase inhibitors (2013-10-22),

10. 8445476 - Carbacephem β-lactam antibiotics (2013-05-21),

11. 8293769 - CSF-1R inhibitors, compositions, and methods of use (2012-10-23),

12. 8217035 - Pyrimidine derivatives used as PI-3-kinase inhibitors (2012-07-10),

13. 8173647 - PI 3-kinase inhibitors and methods of their use (2012-05-08),

14. 8153843 - Antibacterial agents (2012-04-10),

15. 8101640 - Antibacterial agents (2012-01-24),

Title: The Innovative Journey of Allan S. Wagman

Introduction: Allan S. Wagman, a distinguished inventor based in Belmont, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Allan S. Wagman holds several patents in various technological domains, showcasing his continuous commitment to innovation and creativity.

Career Highlights: Throughout his illustrious career, Allan S. Wagman has been at the forefront of technological advancements, with a focus on developing cutting-edge solutions that have revolutionized the industry.

Collaborations: Allan S. Wagman has collaborated with leading tech companies, research institutions, and universities to further his innovative projects, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Allan S. Wagman's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the tech industry, leaving a lasting impact on the world of technology.